Cidara Therapeutics
CDTX
CDTX
39 hedge funds and large institutions have $28.9M invested in Cidara Therapeutics in 2019 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 10 increasing their positions, 12 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
39
Holders Change
-6
Holders Change %
-13.33%
% of All Funds
0.86%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.07%
New
5
Increased
10
Reduced
12
Closed
11
Calls
$16K
Puts
–
Net Calls
+$16K
Net Calls Change
+$16K
Top Buyers
| 1 |
OFM
Omega Fund Management
Boston,
Massachusetts
|
+$263K |
| 2 |
DMK
David M. Knott
|
+$134K |
| 3 |
Renaissance Technologies
New York
|
+$130K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$97.6K |
| 5 |
BI
BVF Inc
San Francisco,
California
|
+$69.5K |
Top Sellers
| 1 |
PM
Prosight Management
Dallas,
Texas
|
-$603K |
| 2 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
-$484K |
| 3 |
FI
Fosun International
Hong Kong,
China
|
-$481K |
| 4 |
Millennium Management
New York
|
-$318K |
| 5 |
AC
Aisling Capital
New York
|
-$258K |
